mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?

mTOR (mechanistic target of rapamycin) protein kinase acts as a central integrator of nutrient signaling pathways. Besides the immunosuppressive role after solid organ transplantations or in the treatment of some cancers, another promising role of mTOR inhibitor as an antiaging therapeutic has emerg...

Descripción completa

Detalles Bibliográficos
Autores principales: Kezic, Aleksandra, Popovic, Ljiljana, Lalic, Katarina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035806/
https://www.ncbi.nlm.nih.gov/pubmed/30034573
http://dx.doi.org/10.1155/2018/2640342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035806/
https://www.ncbi.nlm.nih.gov/pubmed/30034573
http://dx.doi.org/10.1155/2018/2640342

Ejemplares similares